Second stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994

Urology

Volumn 45, Issue 2, 1995, Pages 173-184

  Stamey, Thomas A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; EPITOPE; ESTERASE; PROSTATE SPECIFIC ANTIGEN; SERINE PROTEINASE;

ADULT; AGE; AGED; ARTICLE; BLOOD; CALIBRATION; FEMALE; HUMAN; IMMUNOASSAY; MALE; METABOLISM; METHODOLOGY; PROSTATE TUMOR; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; STANDARD; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGE FACTORS; AGED; ALPHA 1-ANTICHYMOTRYPSIN; ALPHA-MACROGLOBULINS; CALIBRATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPITOPES; ESTERASES; FEMALE; HUMAN; IMMUNOASSAY; MALE; MIDDLE AGE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE STANDARDS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SERINE ENDOPEPTIDASES; SUPPORT, NON-U.S. GOV'T;

EID: 0029240414     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/0090-4295(95)80001-8     Document Type: Article

References (26)

1. Characterization of seminal plasma prostate specific antigen (PSA) for use as antigen standard in PSA immunoassays
2. 1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones
3. Standardisation and quality assurance
4. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination
5. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men
6. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
7. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
8. Seminal plasma protein p30: simplified purification and evidence for identity with prostate-specific antigen
9. A Microtiter Plate Assay for the Characterization of Serine Proteases by Their Esterase Activity
10. Identity of PSA purified from seminal fluid by different methods: results of amino acid analysis and extinction coefficient
11. Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard.
12. Standardization of immunoassays for prostate-specific antigen. A problem of prostate-specific antigen complexation or a problem of assay design?
13. Standardization of immunoassays for prostate specific antigen: a different view based on experimental observations
14. Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges
15. Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate.
16. Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium
17. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors
18. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age
19. Prostate-specific antigen in milk of lactating women
20. An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands
21. The periurethral glands do not have a clinically significant effect on the serum PSA concentration
22. A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy
23. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies
24. 1-antichymotrypsin
25. 1-antichymotrypsin as an indicator of prostate cancer
26. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer